轴性症状作为帕金森病中短期亚thalamic刺激结果的主要预测因素
Carlo Alberto Artusi1, Claudia Ledda1, Domiziana Rinaldi2
1Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy; SC Neurologia 2U, AOU Città della Salute e della Scienza, Turin, Italy.
Journal of the neurological sciences
|September 29, 2023
概括
脑下核深度大脑刺激显著改善帕金森氏症
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 深度大脑刺激 (DBS) 是对帕金森病 (PD) 的一种公认的治疗方法.
- 需要更明确的定义,在PD患者中预测体底核 (STN) DBS结果的预测因素.
研究的目的:
- 确定帕金森病患者STN-DBS反应的临床和人口预测因素.
- 评估STN-DBS对运动症状,运动障碍,休息时间和日常生活活动 (ADL) 的影响.
主要方法:
- 对接受STN-DBS的181名帕金森病患者的分析.
- 对手术前和1年后的运动功能,运动障碍,休息时间和ADL的比较.
- 多变量线性回归以确定STN-DBS反应的预测因素.
主要成果:
- STN-DBS显著改善了运动症状,运动障碍和"关闭"时间 (P < 0.001).
- 疾病持续时间和手术前对利沃多巴的轴性症状反应是运动改善的关键预测因素.
- 疾病持续时间是缩短"关闭"时间的最强预测因素;轴向利沃多巴反应显示出趋势.
结论:
- 对于帕金森病的运动症状和"休息时间",STN-DBS提供了显著的好处.
- 手术前对levodopa的轴性症状反应和疾病持续时间是STN-DBS疗效的关键预测因素.
- 轴心症状及其对利沃多巴的反应可能在患者选择STN-DBS中发挥关键作用.
相关概念视频
Parkinson's Disease: Treatment
292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590


